Caldwell is highly trusted in representing leading technology and life sciences companies in their initial public offerings and other equity and debt offerings. Our team represents hundreds of investor-backed startups and high-growth companies, as well as high-profile public companies. We advise clients on traditional IPOs, as well as other innovative public offering structures, including direct listings, reverse mergers, and special purpose acquisition company offerings (SPACs). We also hold strong relationships with some of the most dynamic investment banking entities.
Book a complimentary strategy session with one of our attorneys.